Atlas Trials

Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

Clinical trial NCT03455777 · WITHDRAWN

Trial details

NCT number
NCT03455777
Sponsor
Akcea Therapeutics
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Homozygous Familial Hypercholesterolemia
Start date
2018-04-12
Primary completion
2018-09-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.